| 6.9 |
34.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 6.7 |
20.2 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 6.4 |
19.2 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 4.9 |
4.9 |
GO:0032409 |
regulation of transporter activity(GO:0032409) |
| 4.7 |
14.0 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 4.5 |
13.5 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 4.2 |
25.3 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 4.1 |
12.4 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 4.1 |
32.8 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 3.9 |
15.8 |
GO:0035793 |
cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 3.9 |
15.6 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 3.9 |
35.1 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 3.8 |
7.7 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 3.7 |
18.6 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 3.6 |
18.2 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 3.6 |
3.6 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 3.6 |
3.6 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 3.5 |
3.5 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 3.5 |
20.9 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 3.4 |
3.4 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 3.4 |
16.9 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 3.4 |
6.8 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 3.3 |
6.7 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 3.3 |
9.9 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 3.3 |
3.3 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 3.3 |
9.8 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 3.2 |
3.2 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 3.2 |
9.7 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 3.2 |
28.6 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 3.2 |
9.5 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 3.2 |
3.2 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 3.1 |
3.1 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 3.1 |
9.3 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 3.1 |
15.5 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 3.1 |
12.4 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 3.1 |
12.2 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 3.0 |
12.2 |
GO:0021586 |
pons maturation(GO:0021586) |
| 3.0 |
18.2 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 3.0 |
3.0 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 3.0 |
8.9 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 3.0 |
26.7 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 2.9 |
2.9 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 2.9 |
8.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 2.9 |
23.4 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 2.9 |
11.7 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 2.9 |
11.6 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 2.9 |
17.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 2.9 |
8.6 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 2.9 |
5.7 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 2.8 |
14.2 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 2.8 |
2.8 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 2.8 |
8.5 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 2.8 |
14.0 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 2.7 |
11.0 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 2.7 |
8.2 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 2.7 |
8.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 2.7 |
8.1 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 2.7 |
2.7 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 2.7 |
10.8 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 2.7 |
2.7 |
GO:0072239 |
metanephric glomerulus vasculature development(GO:0072239) |
| 2.6 |
7.9 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 2.6 |
7.8 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 2.6 |
2.6 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 2.6 |
2.6 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 2.6 |
7.7 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 2.5 |
7.6 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 2.5 |
7.5 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 2.5 |
7.5 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 2.5 |
7.5 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 2.5 |
7.5 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 2.5 |
9.9 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 2.4 |
9.8 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 2.4 |
2.4 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 2.4 |
9.7 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 2.4 |
2.4 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 2.4 |
4.8 |
GO:2000551 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 2.4 |
4.8 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 2.4 |
9.6 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 2.4 |
4.8 |
GO:0030070 |
insulin processing(GO:0030070) |
| 2.4 |
2.4 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 2.4 |
7.1 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 2.4 |
7.1 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.3 |
2.3 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 2.3 |
7.0 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 2.3 |
7.0 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 2.3 |
2.3 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 2.3 |
2.3 |
GO:0060375 |
regulation of mast cell differentiation(GO:0060375) |
| 2.3 |
2.3 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 2.3 |
2.3 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) |
| 2.3 |
2.3 |
GO:0051238 |
sequestering of metal ion(GO:0051238) |
| 2.3 |
6.9 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 2.3 |
2.3 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 2.3 |
2.3 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 2.3 |
4.5 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 2.3 |
6.8 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 2.3 |
6.8 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 2.2 |
4.5 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 2.2 |
2.2 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 2.2 |
15.6 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 2.2 |
11.1 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 2.2 |
4.4 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 2.2 |
6.6 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 2.2 |
8.8 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 2.2 |
6.6 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 2.2 |
8.8 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 2.2 |
2.2 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 2.2 |
13.2 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 2.2 |
13.1 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 2.2 |
2.2 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 2.2 |
2.2 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 2.1 |
2.1 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 2.1 |
6.3 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 2.1 |
8.4 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 2.1 |
6.3 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 2.1 |
2.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 2.1 |
20.8 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 2.1 |
10.3 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 2.1 |
8.2 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 2.1 |
6.2 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 2.1 |
10.3 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 2.0 |
8.2 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 2.0 |
4.1 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 2.0 |
16.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 2.0 |
2.0 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 2.0 |
8.1 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 2.0 |
12.1 |
GO:0003253 |
cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
| 2.0 |
6.0 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 2.0 |
12.0 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 2.0 |
8.0 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 2.0 |
11.9 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 2.0 |
5.9 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 2.0 |
2.0 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 2.0 |
17.7 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 2.0 |
5.9 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 2.0 |
2.0 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 2.0 |
2.0 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 2.0 |
2.0 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 2.0 |
2.0 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 2.0 |
9.8 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 1.9 |
7.7 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 1.9 |
5.8 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.9 |
3.8 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 1.9 |
5.7 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) |
| 1.9 |
7.6 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 1.9 |
5.7 |
GO:0038093 |
positive regulation of mast cell cytokine production(GO:0032765) Fc receptor signaling pathway(GO:0038093) |
| 1.9 |
3.8 |
GO:0072053 |
establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 1.9 |
5.6 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 1.9 |
1.9 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.9 |
3.7 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 1.9 |
20.6 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 1.9 |
3.7 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 1.9 |
1.9 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.8 |
1.8 |
GO:2001046 |
positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 1.8 |
1.8 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.8 |
5.5 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.8 |
20.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.8 |
3.6 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 1.8 |
1.8 |
GO:1902661 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 1.8 |
14.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 1.8 |
7.2 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 1.8 |
5.4 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.8 |
32.4 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.8 |
3.6 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 1.8 |
5.3 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 1.8 |
1.8 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 1.8 |
16.0 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 1.8 |
12.4 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 1.8 |
5.3 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.8 |
12.3 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 1.7 |
5.2 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 1.7 |
7.0 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 1.7 |
5.2 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 1.7 |
3.5 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 1.7 |
3.5 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 1.7 |
5.2 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 1.7 |
5.2 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 1.7 |
10.4 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.7 |
5.2 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 1.7 |
6.9 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 1.7 |
6.9 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 1.7 |
5.1 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 1.7 |
5.1 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 1.7 |
15.3 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 1.7 |
5.1 |
GO:0002586 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.7 |
54.3 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 1.7 |
35.6 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 1.7 |
6.8 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.7 |
5.1 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 1.7 |
10.1 |
GO:0002283 |
neutrophil activation involved in immune response(GO:0002283) |
| 1.7 |
5.1 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 1.7 |
5.0 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 1.7 |
6.7 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.7 |
5.0 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 1.7 |
16.7 |
GO:0015824 |
proline transport(GO:0015824) |
| 1.7 |
11.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 1.7 |
53.2 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 1.7 |
5.0 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 1.7 |
1.7 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 1.6 |
41.2 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 1.6 |
14.8 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 1.6 |
8.2 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 1.6 |
11.4 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 1.6 |
4.9 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 1.6 |
1.6 |
GO:0007620 |
copulation(GO:0007620) |
| 1.6 |
4.9 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 1.6 |
1.6 |
GO:0097491 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 1.6 |
3.2 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.6 |
17.7 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 1.6 |
6.4 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 1.6 |
17.6 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 1.6 |
8.0 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 1.6 |
9.5 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 1.6 |
6.3 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.6 |
7.9 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 1.6 |
9.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 1.6 |
25.2 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 1.6 |
3.2 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 1.6 |
17.3 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.6 |
4.7 |
GO:0031641 |
regulation of myelination(GO:0031641) |
| 1.6 |
4.7 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 1.6 |
11.0 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 1.6 |
9.4 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 1.6 |
4.7 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 1.6 |
6.2 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 1.5 |
6.2 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 1.5 |
15.4 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 1.5 |
1.5 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 1.5 |
7.7 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 1.5 |
4.6 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.5 |
7.7 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 1.5 |
13.8 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 1.5 |
3.1 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 1.5 |
1.5 |
GO:0048819 |
regulation of hair follicle maturation(GO:0048819) regulation of catagen(GO:0051794) |
| 1.5 |
6.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 1.5 |
4.6 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.5 |
1.5 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 1.5 |
4.6 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 1.5 |
15.2 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 1.5 |
1.5 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 1.5 |
1.5 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.5 |
10.6 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.5 |
6.0 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 1.5 |
3.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.5 |
3.0 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 1.5 |
6.0 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 1.5 |
16.4 |
GO:0019835 |
cytolysis(GO:0019835) |
| 1.5 |
1.5 |
GO:0043299 |
leukocyte degranulation(GO:0043299) |
| 1.5 |
11.8 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 1.5 |
3.0 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 1.5 |
4.4 |
GO:0060066 |
oviduct development(GO:0060066) |
| 1.5 |
14.7 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 1.5 |
1.5 |
GO:0072186 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 1.5 |
7.3 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 1.5 |
4.4 |
GO:0021610 |
facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
| 1.5 |
16.1 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 1.5 |
4.4 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 1.5 |
14.6 |
GO:1900193 |
regulation of oocyte maturation(GO:1900193) |
| 1.5 |
43.8 |
GO:0007616 |
long-term memory(GO:0007616) |
| 1.4 |
18.8 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.4 |
1.4 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.4 |
2.9 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 1.4 |
7.2 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 1.4 |
5.7 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 1.4 |
5.7 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 1.4 |
18.5 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 1.4 |
1.4 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 1.4 |
4.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 1.4 |
4.2 |
GO:0060214 |
stem cell fate specification(GO:0048866) endocardium formation(GO:0060214) |
| 1.4 |
14.0 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 1.4 |
7.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.4 |
5.6 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 1.4 |
2.8 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 1.4 |
1.4 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 1.4 |
13.8 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 1.4 |
8.3 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.4 |
1.4 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 1.4 |
4.1 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 1.4 |
5.5 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 1.4 |
2.7 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 1.4 |
5.4 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.4 |
2.7 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 1.4 |
5.4 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 1.4 |
5.4 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.4 |
28.4 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 1.3 |
5.4 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 1.3 |
5.4 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 1.3 |
1.3 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 1.3 |
5.4 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 1.3 |
5.4 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 1.3 |
4.0 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 1.3 |
14.6 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 1.3 |
14.6 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.3 |
4.0 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 1.3 |
6.6 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 1.3 |
4.0 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 1.3 |
2.6 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 1.3 |
4.0 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 1.3 |
1.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 1.3 |
5.2 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.3 |
1.3 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 1.3 |
2.6 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 1.3 |
3.9 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 1.3 |
7.8 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 1.3 |
10.4 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 1.3 |
9.1 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 1.3 |
1.3 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 1.3 |
3.9 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 1.3 |
5.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 1.3 |
3.9 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.3 |
1.3 |
GO:0048289 |
isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 1.3 |
1.3 |
GO:0060455 |
regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
| 1.3 |
10.2 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 1.3 |
1.3 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 1.3 |
5.1 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 1.3 |
1.3 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.3 |
3.8 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.3 |
2.5 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 1.3 |
7.6 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) |
| 1.3 |
8.8 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 1.3 |
3.8 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.3 |
2.5 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.3 |
1.3 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 1.2 |
3.7 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 1.2 |
3.7 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 1.2 |
8.7 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.2 |
6.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 1.2 |
2.5 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 1.2 |
3.7 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 1.2 |
11.1 |
GO:0044090 |
positive regulation of vacuole organization(GO:0044090) |
| 1.2 |
7.4 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 1.2 |
1.2 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 1.2 |
27.1 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 1.2 |
8.6 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 1.2 |
3.7 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 1.2 |
2.5 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 1.2 |
3.7 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.2 |
25.8 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 1.2 |
4.9 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 1.2 |
7.3 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.2 |
3.7 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 1.2 |
8.5 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 1.2 |
1.2 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 1.2 |
2.4 |
GO:0001803 |
type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 1.2 |
3.6 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 1.2 |
1.2 |
GO:0060437 |
lung growth(GO:0060437) |
| 1.2 |
2.4 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.2 |
8.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 1.2 |
2.4 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 1.2 |
1.2 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 1.2 |
2.4 |
GO:0071499 |
response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 1.2 |
6.0 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 1.2 |
4.8 |
GO:2000543 |
positive regulation of gastrulation(GO:2000543) |
| 1.2 |
4.8 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 1.2 |
4.8 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 1.2 |
3.6 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.2 |
1.2 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 1.2 |
2.4 |
GO:0051580 |
regulation of neurotransmitter uptake(GO:0051580) |
| 1.2 |
2.4 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 1.2 |
5.9 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 1.2 |
2.4 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 1.2 |
4.7 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.2 |
1.2 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 1.2 |
40.1 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 1.2 |
4.7 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.2 |
4.7 |
GO:0045113 |
integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
| 1.2 |
7.0 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 1.2 |
2.3 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 1.2 |
1.2 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 1.2 |
3.5 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 1.2 |
2.3 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 1.2 |
4.6 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 1.2 |
16.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 1.1 |
6.8 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 1.1 |
3.4 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 1.1 |
4.6 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 1.1 |
3.4 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 1.1 |
6.8 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 1.1 |
6.8 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 1.1 |
4.5 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.1 |
2.2 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 1.1 |
5.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 1.1 |
1.1 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 1.1 |
2.2 |
GO:0001820 |
serotonin secretion(GO:0001820) |
| 1.1 |
10.0 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 1.1 |
5.6 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
| 1.1 |
1.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 1.1 |
4.4 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 1.1 |
3.3 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 1.1 |
1.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 1.1 |
11.0 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 1.1 |
1.1 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 1.1 |
2.2 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 1.1 |
2.2 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 1.1 |
3.3 |
GO:0032474 |
otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 1.1 |
1.1 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 1.1 |
6.5 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 1.1 |
25.0 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 1.1 |
4.3 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 1.1 |
1.1 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 1.1 |
7.6 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 1.1 |
2.2 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 1.1 |
3.2 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 1.1 |
4.3 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 1.1 |
5.4 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.1 |
5.4 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 1.1 |
39.7 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 1.1 |
1.1 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 1.1 |
1.1 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 1.1 |
4.3 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 1.1 |
1.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 1.1 |
4.3 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 1.1 |
9.6 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 1.1 |
12.8 |
GO:0046697 |
decidualization(GO:0046697) |
| 1.1 |
1.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 1.1 |
4.2 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 1.1 |
4.2 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 1.1 |
1.1 |
GO:0019042 |
viral latency(GO:0019042) |
| 1.1 |
2.1 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 1.1 |
4.2 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 1.0 |
17.8 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 1.0 |
10.4 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 1.0 |
1.0 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 1.0 |
4.2 |
GO:2000848 |
positive regulation of corticosteroid hormone secretion(GO:2000848) |
| 1.0 |
4.2 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 1.0 |
4.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 1.0 |
8.3 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 1.0 |
1.0 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 1.0 |
17.6 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 1.0 |
3.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 1.0 |
1.0 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.0 |
5.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 1.0 |
8.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 1.0 |
5.1 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 1.0 |
6.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 1.0 |
1.0 |
GO:0045777 |
positive regulation of blood pressure(GO:0045777) |
| 1.0 |
1.0 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 1.0 |
1.0 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 1.0 |
10.2 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.0 |
13.3 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 1.0 |
1.0 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 1.0 |
1.0 |
GO:0061743 |
motor learning(GO:0061743) |
| 1.0 |
8.2 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.0 |
1.0 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 1.0 |
1.0 |
GO:0014831 |
gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 1.0 |
7.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 1.0 |
3.0 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 1.0 |
8.1 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 1.0 |
4.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 1.0 |
1.0 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 1.0 |
3.0 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 1.0 |
11.1 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 1.0 |
3.0 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 1.0 |
6.0 |
GO:0015816 |
glycine transport(GO:0015816) |
| 1.0 |
1.0 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 1.0 |
1.0 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 1.0 |
1.0 |
GO:0070920 |
regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
| 1.0 |
8.0 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 1.0 |
4.0 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 1.0 |
7.9 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 1.0 |
3.9 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 1.0 |
11.8 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 1.0 |
4.9 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 1.0 |
2.9 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.0 |
2.9 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 1.0 |
8.8 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 1.0 |
1.0 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 1.0 |
3.9 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 1.0 |
1.0 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 1.0 |
5.8 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.0 |
1.9 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 1.0 |
3.9 |
GO:0002524 |
hypersensitivity(GO:0002524) |
| 1.0 |
1.9 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 1.0 |
1.0 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 1.0 |
2.9 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 1.0 |
1.9 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 1.0 |
1.0 |
GO:2000277 |
positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 1.0 |
3.9 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 1.0 |
1.0 |
GO:0003198 |
epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
| 1.0 |
1.0 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 1.0 |
1.0 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 1.0 |
5.8 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 1.0 |
2.9 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.0 |
2.9 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 1.0 |
1.9 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 1.0 |
6.7 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) fibroblast activation(GO:0072537) regulation of hepatic stellate cell activation(GO:2000489) |
| 1.0 |
1.0 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.9 |
2.8 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.9 |
3.8 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.9 |
2.8 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.9 |
4.7 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.9 |
1.9 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.9 |
4.7 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.9 |
0.9 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.9 |
3.8 |
GO:1903358 |
regulation of Golgi organization(GO:1903358) |
| 0.9 |
3.7 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.9 |
4.7 |
GO:0071404 |
cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.9 |
2.8 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.9 |
2.8 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.9 |
3.7 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.9 |
1.9 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.9 |
12.1 |
GO:0071872 |
response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
| 0.9 |
2.8 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.9 |
13.0 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.9 |
0.9 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.9 |
2.8 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.9 |
2.8 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 0.9 |
2.8 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.9 |
1.8 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.9 |
3.7 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.9 |
4.6 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.9 |
2.8 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.9 |
1.8 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.9 |
1.8 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.9 |
2.7 |
GO:0006598 |
polyamine catabolic process(GO:0006598) spermine catabolic process(GO:0046208) |
| 0.9 |
4.6 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.9 |
7.3 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.9 |
1.8 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.9 |
6.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.9 |
13.6 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.9 |
13.6 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.9 |
4.5 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.9 |
2.7 |
GO:0046016 |
positive regulation of transcription by glucose(GO:0046016) |
| 0.9 |
9.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.9 |
6.3 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.9 |
1.8 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.9 |
4.5 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.9 |
18.9 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.9 |
0.9 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.9 |
5.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.9 |
4.5 |
GO:0070099 |
regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.9 |
1.8 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.9 |
3.6 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.9 |
5.3 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.9 |
0.9 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.9 |
1.8 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.9 |
2.7 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.9 |
11.5 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.9 |
5.3 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.9 |
0.9 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.9 |
3.5 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.9 |
2.6 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.9 |
1.7 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.9 |
6.1 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.9 |
3.5 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.9 |
0.9 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.9 |
1.7 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.9 |
0.9 |
GO:0055094 |
response to lipoprotein particle(GO:0055094) |
| 0.9 |
1.7 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.9 |
2.6 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.9 |
2.6 |
GO:0060317 |
cardiac epithelial to mesenchymal transition(GO:0060317) |
| 0.9 |
1.7 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.9 |
1.7 |
GO:2000379 |
positive regulation of reactive oxygen species metabolic process(GO:2000379) |
| 0.9 |
0.9 |
GO:0002579 |
positive regulation of antigen processing and presentation(GO:0002579) |
| 0.9 |
2.6 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.9 |
1.7 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.9 |
4.3 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.9 |
0.9 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
| 0.9 |
1.7 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.9 |
0.9 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.9 |
0.9 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
| 0.9 |
3.4 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.9 |
0.9 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.9 |
4.3 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.9 |
0.9 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.8 |
5.9 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.8 |
1.7 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.8 |
1.7 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.8 |
2.5 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.8 |
1.7 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.8 |
13.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.8 |
1.7 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.8 |
5.0 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.8 |
1.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.8 |
2.5 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.8 |
2.5 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.8 |
1.7 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.8 |
0.8 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.8 |
0.8 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.8 |
0.8 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.8 |
12.4 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.8 |
5.0 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.8 |
9.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.8 |
2.5 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.8 |
0.8 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.8 |
1.6 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.8 |
1.6 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.8 |
0.8 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.8 |
7.4 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.8 |
0.8 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.8 |
1.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.8 |
4.9 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.8 |
15.6 |
GO:0060306 |
regulation of membrane repolarization(GO:0060306) |
| 0.8 |
22.9 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.8 |
1.6 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.8 |
12.3 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.8 |
6.5 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.8 |
1.6 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.8 |
4.9 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.8 |
5.7 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
| 0.8 |
0.8 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.8 |
8.1 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.8 |
4.0 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.8 |
5.6 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.8 |
1.6 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.8 |
3.2 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.8 |
11.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.8 |
0.8 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.8 |
6.4 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.8 |
4.0 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.8 |
0.8 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.8 |
0.8 |
GO:0046880 |
regulation of gonadotropin secretion(GO:0032276) regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.8 |
1.6 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.8 |
2.4 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.8 |
1.6 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.8 |
3.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.8 |
46.8 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.8 |
4.8 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.8 |
0.8 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.8 |
0.8 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.8 |
1.6 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) GDP-L-fucose metabolic process(GO:0046368) |
| 0.8 |
3.9 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.8 |
7.1 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.8 |
3.9 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.8 |
0.8 |
GO:0097242 |
beta-amyloid clearance(GO:0097242) |
| 0.8 |
31.2 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.8 |
3.1 |
GO:2000828 |
regulation of parathyroid hormone secretion(GO:2000828) |
| 0.8 |
2.3 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.8 |
0.8 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.8 |
1.6 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.8 |
8.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.8 |
0.8 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.8 |
2.3 |
GO:0010935 |
macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
| 0.8 |
2.3 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.8 |
0.8 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.8 |
6.9 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.8 |
3.8 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.8 |
2.3 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.8 |
13.0 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.8 |
0.8 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.8 |
4.6 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.8 |
2.3 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.8 |
3.0 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.8 |
2.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.8 |
2.3 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.8 |
0.8 |
GO:0042160 |
lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) negative regulation of lymphocyte migration(GO:2000402) |
| 0.8 |
0.8 |
GO:2000345 |
regulation of hepatocyte proliferation(GO:2000345) |
| 0.8 |
1.5 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.8 |
12.0 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.8 |
6.0 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.8 |
4.5 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.7 |
3.0 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.7 |
1.5 |
GO:0009838 |
abscission(GO:0009838) |
| 0.7 |
5.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.7 |
8.9 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.7 |
0.7 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.7 |
5.9 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.7 |
14.8 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.7 |
1.5 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
| 0.7 |
2.2 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.7 |
2.2 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.7 |
3.6 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.7 |
0.7 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.7 |
2.2 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.7 |
4.4 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.7 |
2.2 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.7 |
2.2 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.7 |
8.0 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.7 |
2.9 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.7 |
2.2 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.7 |
1.4 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.7 |
2.2 |
GO:2000316 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.7 |
2.9 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.7 |
2.2 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.7 |
0.7 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.7 |
0.7 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.7 |
1.4 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.7 |
0.7 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.7 |
2.1 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.7 |
3.5 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.7 |
0.7 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.7 |
0.7 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.7 |
5.0 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.7 |
1.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.7 |
11.3 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.7 |
7.0 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.7 |
2.8 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.7 |
1.4 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.7 |
0.7 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.7 |
2.1 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.7 |
2.1 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.7 |
4.9 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.7 |
3.5 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.7 |
4.1 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.7 |
4.1 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.7 |
2.8 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.7 |
0.7 |
GO:1903975 |
regulation of glial cell migration(GO:1903975) |
| 0.7 |
2.1 |
GO:0001845 |
phagolysosome assembly(GO:0001845) |
| 0.7 |
1.4 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.7 |
2.7 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.7 |
2.7 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.7 |
1.4 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.7 |
6.8 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.7 |
12.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.7 |
2.0 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.7 |
4.1 |
GO:2000785 |
regulation of vacuole organization(GO:0044088) regulation of autophagosome assembly(GO:2000785) |
| 0.7 |
1.4 |
GO:0010875 |
positive regulation of cholesterol efflux(GO:0010875) |
| 0.7 |
0.7 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.7 |
0.7 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.7 |
1.3 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.7 |
1.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.7 |
1.3 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.7 |
1.3 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.7 |
2.0 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.7 |
0.7 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.7 |
13.3 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.7 |
0.7 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.7 |
1.3 |
GO:0006833 |
water transport(GO:0006833) |
| 0.7 |
4.0 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) regulation of mononuclear cell migration(GO:0071675) |
| 0.7 |
2.7 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.7 |
3.3 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.7 |
2.0 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.7 |
1.3 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.7 |
0.7 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.7 |
3.3 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.7 |
3.3 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.7 |
3.3 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.7 |
2.6 |
GO:1901163 |
trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
| 0.7 |
0.7 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.7 |
2.0 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.7 |
2.0 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.7 |
0.7 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.7 |
2.6 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.7 |
2.0 |
GO:0010612 |
regulation of cardiac muscle adaptation(GO:0010612) |
| 0.7 |
6.5 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.7 |
4.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.7 |
0.7 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.6 |
3.9 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.6 |
0.6 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.6 |
3.2 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.6 |
1.9 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.6 |
0.6 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.6 |
9.6 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.6 |
0.6 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 0.6 |
2.5 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.6 |
1.3 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.6 |
0.6 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.6 |
1.3 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.6 |
10.6 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.6 |
0.6 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.6 |
10.0 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.6 |
3.1 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.6 |
1.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.6 |
0.6 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.6 |
0.6 |
GO:0072071 |
mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
| 0.6 |
1.9 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.6 |
2.5 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.6 |
1.2 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.6 |
17.3 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.6 |
0.6 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.6 |
0.6 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.6 |
1.2 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.6 |
0.6 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.6 |
6.1 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.6 |
0.6 |
GO:0001916 |
positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.6 |
1.8 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.6 |
4.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.6 |
1.2 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.6 |
2.4 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.6 |
7.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.6 |
4.8 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.6 |
11.4 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.6 |
1.2 |
GO:0035150 |
regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
| 0.6 |
2.4 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.6 |
1.2 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.6 |
2.4 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.6 |
0.6 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.6 |
9.5 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.6 |
4.8 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.6 |
2.4 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.6 |
1.8 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.6 |
0.6 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.6 |
1.8 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.6 |
4.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.6 |
8.7 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.6 |
1.2 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.6 |
2.3 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.6 |
3.5 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.6 |
2.3 |
GO:0032928 |
regulation of superoxide anion generation(GO:0032928) negative regulation of superoxide anion generation(GO:0032929) |
| 0.6 |
1.7 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.6 |
1.2 |
GO:0009713 |
catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.6 |
1.7 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.6 |
7.5 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.6 |
2.9 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.6 |
1.7 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.6 |
0.6 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.6 |
0.6 |
GO:0072676 |
lymphocyte migration(GO:0072676) |
| 0.6 |
2.9 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.6 |
5.1 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.6 |
16.5 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.6 |
1.1 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.6 |
2.3 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.6 |
4.0 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.6 |
1.1 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.6 |
3.4 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.6 |
6.8 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.6 |
0.6 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.6 |
2.3 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.6 |
1.1 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.6 |
0.6 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.6 |
1.7 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.6 |
0.6 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.6 |
5.6 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.6 |
2.8 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.6 |
0.6 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.6 |
1.7 |
GO:0019348 |
polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.6 |
0.6 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.6 |
2.8 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.6 |
1.7 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.5 |
2.7 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.5 |
0.5 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.5 |
3.8 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.5 |
1.1 |
GO:0010226 |
response to lithium ion(GO:0010226) |
| 0.5 |
1.1 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.5 |
1.6 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.5 |
2.7 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.5 |
2.2 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.5 |
2.2 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.5 |
1.6 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.5 |
2.7 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.5 |
8.7 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.5 |
0.5 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.5 |
1.6 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.5 |
2.7 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.5 |
5.3 |
GO:0006839 |
mitochondrial transport(GO:0006839) |
| 0.5 |
2.1 |
GO:1901032 |
negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.5 |
3.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.5 |
8.0 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.5 |
2.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.5 |
1.6 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.5 |
3.2 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.5 |
1.6 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.5 |
8.4 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.5 |
0.5 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.5 |
1.0 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.5 |
8.4 |
GO:1901379 |
regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.5 |
0.5 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.5 |
1.0 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.5 |
0.5 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.5 |
1.6 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.5 |
7.8 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.5 |
1.6 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.5 |
1.0 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.5 |
3.1 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.5 |
0.5 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.5 |
2.6 |
GO:0050805 |
negative regulation of synaptic transmission(GO:0050805) |
| 0.5 |
1.5 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.5 |
1.0 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) |
| 0.5 |
1.5 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.5 |
1.0 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.5 |
4.1 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.5 |
3.6 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.5 |
2.0 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.5 |
1.5 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.5 |
1.5 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.5 |
5.1 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.5 |
2.0 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.5 |
1.0 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.5 |
2.5 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.5 |
0.5 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.5 |
2.5 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.5 |
1.0 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.5 |
1.0 |
GO:0042439 |
ethanolamine-containing compound metabolic process(GO:0042439) phosphatidylcholine metabolic process(GO:0046470) |
| 0.5 |
1.5 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.5 |
0.5 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.5 |
0.5 |
GO:0072235 |
distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
| 0.5 |
2.5 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.5 |
2.5 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.5 |
8.5 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.5 |
2.0 |
GO:0002526 |
acute inflammatory response(GO:0002526) |
| 0.5 |
1.5 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.5 |
1.0 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.5 |
1.5 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.5 |
1.5 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.5 |
0.5 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.5 |
0.5 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.5 |
0.5 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.5 |
4.0 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.5 |
1.5 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.5 |
0.5 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.5 |
2.5 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.5 |
3.5 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.5 |
3.5 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.5 |
1.5 |
GO:0001759 |
organ induction(GO:0001759) |
| 0.5 |
1.0 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.5 |
1.0 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.5 |
0.5 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.5 |
0.5 |
GO:0019377 |
glycolipid catabolic process(GO:0019377) |
| 0.5 |
1.5 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.5 |
2.9 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.5 |
1.0 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.5 |
1.9 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.5 |
1.0 |
GO:0072126 |
positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
| 0.5 |
1.9 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.5 |
0.5 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.5 |
2.9 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.5 |
0.5 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.5 |
1.0 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.5 |
5.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.5 |
5.2 |
GO:0055012 |
ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.5 |
3.8 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.5 |
0.5 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.5 |
5.2 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.5 |
0.5 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.5 |
2.4 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.5 |
3.8 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.5 |
1.9 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.5 |
0.9 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.5 |
3.3 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.5 |
0.9 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.5 |
2.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.5 |
1.4 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.5 |
1.4 |
GO:0044003 |
modification by symbiont of host morphology or physiology(GO:0044003) |
| 0.5 |
0.5 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.5 |
4.2 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.5 |
0.9 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.5 |
0.5 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.5 |
7.3 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.5 |
3.7 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.5 |
6.9 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.5 |
1.8 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.5 |
1.4 |
GO:0034698 |
response to gonadotropin(GO:0034698) |
| 0.5 |
1.8 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.5 |
0.5 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.5 |
1.8 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.5 |
3.2 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.5 |
5.0 |
GO:0060547 |
negative regulation of necrotic cell death(GO:0060547) |
| 0.5 |
1.8 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.5 |
1.8 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.5 |
6.3 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.5 |
0.9 |
GO:0021626 |
hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) |
| 0.4 |
2.7 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.4 |
0.9 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 0.4 |
2.7 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.4 |
0.9 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.4 |
6.7 |
GO:0042775 |
mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.4 |
3.6 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.4 |
0.4 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.4 |
1.3 |
GO:0006787 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
| 0.4 |
0.9 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.4 |
0.4 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 0.4 |
0.9 |
GO:0043406 |
positive regulation of MAP kinase activity(GO:0043406) |
| 0.4 |
1.8 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.4 |
1.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.4 |
2.6 |
GO:0042391 |
regulation of membrane potential(GO:0042391) |
| 0.4 |
0.4 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.4 |
0.4 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.4 |
1.7 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.4 |
1.3 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.4 |
6.1 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.4 |
0.9 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.4 |
1.7 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.4 |
1.7 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.4 |
0.4 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.4 |
3.9 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.4 |
1.3 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 |
1.7 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.4 |
1.7 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.4 |
3.0 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.4 |
1.7 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.4 |
4.7 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.4 |
0.4 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.4 |
2.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.4 |
5.5 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.4 |
1.7 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 |
6.3 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.4 |
0.8 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.4 |
1.7 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.4 |
1.3 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.4 |
5.8 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.4 |
4.2 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.4 |
1.2 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.4 |
3.7 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.4 |
0.4 |
GO:1900272 |
negative regulation of long-term synaptic potentiation(GO:1900272) |
| 0.4 |
1.2 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.4 |
2.1 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.4 |
0.8 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.4 |
2.1 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.4 |
3.7 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.4 |
1.6 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.4 |
1.2 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.4 |
0.8 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.4 |
5.3 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.4 |
1.2 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.4 |
1.6 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.4 |
2.0 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.4 |
1.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.4 |
4.0 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.4 |
2.0 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.4 |
0.4 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.4 |
16.4 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.4 |
0.8 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.4 |
0.4 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.4 |
0.8 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.4 |
1.2 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.4 |
1.2 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.4 |
6.3 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.4 |
6.3 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.4 |
1.2 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.4 |
6.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.4 |
4.7 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.4 |
0.8 |
GO:0046618 |
drug export(GO:0046618) |
| 0.4 |
2.0 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.4 |
0.8 |
GO:0032660 |
regulation of interleukin-17 production(GO:0032660) |
| 0.4 |
1.9 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.4 |
1.9 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.4 |
2.3 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.4 |
4.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.4 |
7.6 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.4 |
5.7 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.4 |
1.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.4 |
2.3 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.4 |
3.8 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.4 |
1.5 |
GO:1905097 |
regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.4 |
4.5 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.4 |
0.4 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.4 |
0.4 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.4 |
2.2 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.4 |
0.7 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.4 |
4.4 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.4 |
2.6 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.4 |
1.1 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.4 |
0.4 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.4 |
1.1 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.4 |
4.0 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.4 |
5.5 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.4 |
0.4 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.4 |
2.2 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.4 |
0.4 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.4 |
0.4 |
GO:0042832 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.4 |
0.7 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 |
0.7 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.4 |
1.1 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 0.4 |
10.4 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.4 |
0.4 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.4 |
1.8 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.4 |
1.1 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.4 |
0.7 |
GO:1901727 |
positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.4 |
17.9 |
GO:0099531 |
presynaptic process involved in chemical synaptic transmission(GO:0099531) |
| 0.4 |
0.7 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.4 |
1.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.4 |
0.4 |
GO:0044320 |
cellular response to leptin stimulus(GO:0044320) |
| 0.4 |
0.4 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.4 |
3.2 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.4 |
2.8 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.4 |
0.4 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.3 |
1.0 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.3 |
2.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.3 |
2.1 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.3 |
2.4 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.3 |
12.5 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.3 |
1.0 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.3 |
0.3 |
GO:0007006 |
mitochondrial membrane organization(GO:0007006) |
| 0.3 |
0.7 |
GO:0031644 |
regulation of neurological system process(GO:0031644) |
| 0.3 |
0.3 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.3 |
0.3 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.3 |
0.3 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.3 |
0.7 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.3 |
2.4 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 |
2.4 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.3 |
4.1 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.3 |
2.0 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.3 |
6.0 |
GO:0008593 |
regulation of Notch signaling pathway(GO:0008593) |
| 0.3 |
1.0 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.3 |
0.3 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.3 |
3.7 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.3 |
1.0 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.3 |
1.7 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
0.3 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.3 |
4.6 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
0.7 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.3 |
1.0 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.3 |
0.3 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.3 |
2.0 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.3 |
0.3 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.3 |
0.3 |
GO:0060384 |
innervation(GO:0060384) |
| 0.3 |
0.6 |
GO:0019076 |
viral release from host cell(GO:0019076) |
| 0.3 |
0.3 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.3 |
0.6 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.3 |
1.9 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.3 |
1.3 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.3 |
0.6 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.3 |
0.3 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.3 |
3.2 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 |
0.6 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.3 |
0.3 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.3 |
1.3 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.3 |
2.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 |
0.3 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.3 |
0.9 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 |
2.5 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.3 |
0.3 |
GO:0048023 |
positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.3 |
0.9 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.3 |
0.6 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 |
4.7 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.3 |
0.9 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.3 |
0.6 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.3 |
0.6 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.3 |
0.9 |
GO:0015868 |
purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.3 |
4.3 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.3 |
1.2 |
GO:0043482 |
pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
| 0.3 |
2.5 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.3 |
0.9 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.3 |
0.9 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.3 |
0.9 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.3 |
0.6 |
GO:0033033 |
regulation of myeloid cell apoptotic process(GO:0033032) negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.3 |
5.1 |
GO:1901661 |
quinone metabolic process(GO:1901661) |
| 0.3 |
3.9 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.3 |
1.2 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.3 |
0.3 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.3 |
0.9 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 |
1.8 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.3 |
0.6 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.3 |
2.1 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.3 |
0.6 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.3 |
2.1 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.3 |
0.3 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.3 |
8.5 |
GO:0015992 |
proton transport(GO:0015992) |
| 0.3 |
0.9 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.3 |
0.3 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.3 |
1.7 |
GO:1904705 |
regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.3 |
0.6 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.3 |
0.6 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.3 |
0.3 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
| 0.3 |
2.9 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.3 |
3.8 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.3 |
0.3 |
GO:0006818 |
hydrogen transport(GO:0006818) |
| 0.3 |
4.3 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.3 |
2.3 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.3 |
0.9 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.3 |
0.9 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.3 |
5.7 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.3 |
0.3 |
GO:0006778 |
porphyrin-containing compound metabolic process(GO:0006778) |
| 0.3 |
0.3 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.3 |
0.6 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.3 |
18.9 |
GO:0006814 |
sodium ion transport(GO:0006814) |
| 0.3 |
0.3 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.3 |
0.8 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.3 |
2.2 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.3 |
1.1 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.3 |
0.3 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 |
0.8 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 |
3.1 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.3 |
2.8 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.3 |
1.1 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.3 |
0.3 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.3 |
1.4 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.3 |
2.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
1.9 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.3 |
23.5 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.3 |
0.8 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.3 |
0.5 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.3 |
0.5 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 |
0.5 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.3 |
1.9 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.3 |
2.2 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.3 |
3.3 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.3 |
3.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.3 |
0.5 |
GO:1901072 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
| 0.3 |
5.9 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.3 |
1.6 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.3 |
0.5 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.3 |
2.4 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.3 |
3.2 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.3 |
1.1 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.3 |
0.5 |
GO:2000108 |
positive regulation of leukocyte apoptotic process(GO:2000108) |
| 0.3 |
2.6 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.3 |
1.3 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.3 |
2.6 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.3 |
2.9 |
GO:0015800 |
acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
| 0.3 |
0.3 |
GO:0002691 |
regulation of cellular extravasation(GO:0002691) |
| 0.3 |
1.8 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.3 |
0.5 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 |
1.3 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.3 |
2.6 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.3 |
1.5 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 |
1.8 |
GO:0032094 |
response to food(GO:0032094) |
| 0.3 |
0.5 |
GO:1904729 |
intestinal cholesterol absorption(GO:0030299) regulation of intestinal cholesterol absorption(GO:0030300) lipid digestion(GO:0044241) intestinal lipid absorption(GO:0098856) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.3 |
0.5 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.3 |
0.3 |
GO:0048246 |
macrophage chemotaxis(GO:0048246) |
| 0.3 |
0.3 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.2 |
0.2 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.2 |
0.5 |
GO:0042745 |
circadian sleep/wake cycle(GO:0042745) |
| 0.2 |
0.5 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.2 |
0.5 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.2 |
0.7 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 |
16.6 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.2 |
0.5 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.2 |
1.9 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.2 |
0.5 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.2 |
8.3 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.2 |
2.1 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 |
0.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
1.4 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
0.7 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.2 |
0.7 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.2 |
1.2 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.2 |
0.7 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
1.8 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.2 |
0.2 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.2 |
0.5 |
GO:0001710 |
mesodermal cell fate commitment(GO:0001710) |
| 0.2 |
0.2 |
GO:2001169 |
regulation of ATP biosynthetic process(GO:2001169) |
| 0.2 |
0.7 |
GO:0071105 |
response to interleukin-2(GO:0070669) response to interleukin-11(GO:0071105) |
| 0.2 |
0.5 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
0.9 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.2 |
5.4 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.2 |
0.5 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
2.7 |
GO:0032024 |
positive regulation of insulin secretion(GO:0032024) |
| 0.2 |
2.7 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.2 |
2.2 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.2 |
0.7 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.2 |
8.0 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.2 |
1.1 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
1.1 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
3.0 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.2 |
2.4 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.2 |
0.6 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.2 |
0.9 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.2 |
2.1 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.2 |
1.9 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 |
0.2 |
GO:0010939 |
regulation of necrotic cell death(GO:0010939) |
| 0.2 |
0.6 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 |
2.8 |
GO:0090174 |
organelle membrane fusion(GO:0090174) |
| 0.2 |
1.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 |
4.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
0.4 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
0.2 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.2 |
0.2 |
GO:0010883 |
regulation of lipid storage(GO:0010883) positive regulation of lipid storage(GO:0010884) |
| 0.2 |
1.7 |
GO:0051181 |
cofactor transport(GO:0051181) |
| 0.2 |
2.3 |
GO:0010737 |
protein kinase A signaling(GO:0010737) |
| 0.2 |
0.6 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.2 |
0.8 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
11.0 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.2 |
0.2 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.2 |
0.4 |
GO:0032731 |
positive regulation of interleukin-1 beta production(GO:0032731) |
| 0.2 |
0.2 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.2 |
0.6 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.2 |
0.4 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 |
2.4 |
GO:0016525 |
negative regulation of angiogenesis(GO:0016525) |
| 0.2 |
1.8 |
GO:1901985 |
positive regulation of protein acetylation(GO:1901985) |
| 0.2 |
0.4 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 |
0.4 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.2 |
0.6 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 |
0.2 |
GO:0043491 |
protein kinase B signaling(GO:0043491) |
| 0.2 |
0.4 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.2 |
0.4 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.2 |
1.2 |
GO:0072511 |
divalent inorganic cation transport(GO:0072511) |
| 0.2 |
1.2 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.2 |
0.4 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
0.2 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.2 |
0.6 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.2 |
1.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.2 |
0.7 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
1.5 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.2 |
0.4 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
2.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 |
0.7 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.2 |
2.2 |
GO:0060433 |
bronchus development(GO:0060433) |
| 0.2 |
0.2 |
GO:1900120 |
regulation of receptor binding(GO:1900120) |
| 0.2 |
0.4 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.2 |
0.5 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.2 |
4.5 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.2 |
0.2 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.2 |
0.2 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.2 |
1.1 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.2 |
1.1 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.2 |
1.9 |
GO:0007416 |
synapse assembly(GO:0007416) |
| 0.2 |
0.7 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.2 |
0.4 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.2 |
2.4 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.2 |
2.4 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
0.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 |
0.5 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.2 |
0.3 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.2 |
0.3 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) |
| 0.2 |
2.9 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.2 |
0.9 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
0.5 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.2 |
4.1 |
GO:0032006 |
regulation of TOR signaling(GO:0032006) |
| 0.2 |
3.2 |
GO:0006882 |
cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
| 0.2 |
2.9 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.2 |
0.3 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.2 |
1.8 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 |
3.1 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.2 |
0.2 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.2 |
1.0 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
0.5 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.2 |
1.1 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.2 |
0.2 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.2 |
0.3 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.2 |
1.7 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.2 |
1.9 |
GO:0050710 |
negative regulation of cytokine secretion(GO:0050710) |
| 0.2 |
0.2 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.2 |
3.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
0.2 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.2 |
0.6 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.2 |
0.6 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 |
0.4 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.4 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.1 |
0.1 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.1 |
0.1 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.1 |
0.4 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
1.3 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.1 |
2.8 |
GO:1901216 |
positive regulation of neuron death(GO:1901216) |
| 0.1 |
0.4 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
0.1 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 |
5.1 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.1 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.8 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
1.1 |
GO:0050808 |
synapse organization(GO:0050808) |
| 0.1 |
0.7 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 0.1 |
0.1 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 |
1.1 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 |
0.4 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.1 |
GO:0086009 |
membrane repolarization(GO:0086009) |
| 0.1 |
0.9 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.4 |
GO:1900024 |
regulation of substrate adhesion-dependent cell spreading(GO:1900024) |
| 0.1 |
3.2 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.5 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.1 |
0.3 |
GO:0002832 |
negative regulation of response to biotic stimulus(GO:0002832) |
| 0.1 |
4.5 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.3 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 |
0.3 |
GO:0007632 |
visual behavior(GO:0007632) |
| 0.1 |
0.9 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.3 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.1 |
0.5 |
GO:0001783 |
B cell apoptotic process(GO:0001783) |
| 0.1 |
0.4 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.3 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 |
0.1 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
0.1 |
GO:0032754 |
positive regulation of interleukin-5 production(GO:0032754) |
| 0.1 |
0.6 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.4 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.6 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.7 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.4 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.6 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
2.9 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.7 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
0.5 |
GO:0072102 |
glomerulus morphogenesis(GO:0072102) |
| 0.1 |
1.1 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.1 |
0.2 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.1 |
0.6 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.6 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.1 |
0.7 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
0.1 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.1 |
0.1 |
GO:0046348 |
amino sugar catabolic process(GO:0046348) |
| 0.1 |
0.3 |
GO:0044110 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.1 |
0.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.6 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.3 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.1 |
0.8 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.6 |
GO:0016125 |
sterol metabolic process(GO:0016125) |
| 0.1 |
0.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
1.6 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 |
0.1 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.1 |
0.3 |
GO:0009651 |
response to salt stress(GO:0009651) |
| 0.1 |
1.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.3 |
GO:0019068 |
virion assembly(GO:0019068) |
| 0.1 |
0.2 |
GO:2000152 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.3 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 |
0.5 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.8 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.3 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.1 |
1.6 |
GO:0048167 |
regulation of synaptic plasticity(GO:0048167) |
| 0.1 |
0.4 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.5 |
GO:0051645 |
Golgi localization(GO:0051645) |
| 0.1 |
2.8 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.2 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.1 |
0.6 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 |
1.3 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.2 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
2.9 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.1 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.2 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.1 |
1.0 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.1 |
0.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
0.2 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.1 |
0.4 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.1 |
0.3 |
GO:0050994 |
regulation of lipid catabolic process(GO:0050994) |
| 0.1 |
1.4 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.6 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.1 |
0.1 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.2 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.3 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.2 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.1 |
0.3 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.5 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.1 |
0.2 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.1 |
2.3 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.1 |
0.1 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
1.1 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.3 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.1 |
0.6 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
3.3 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.1 |
0.1 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.1 |
0.1 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
1.2 |
GO:0007596 |
blood coagulation(GO:0007596) |
| 0.1 |
0.8 |
GO:0045834 |
positive regulation of lipid metabolic process(GO:0045834) |
| 0.1 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.1 |
GO:0072044 |
collecting duct development(GO:0072044) |
| 0.1 |
0.1 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.1 |
0.1 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.1 |
0.3 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 |
0.2 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.1 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.0 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.0 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.0 |
0.2 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.4 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.5 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.2 |
GO:0031670 |
cellular response to nutrient(GO:0031670) |
| 0.0 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.2 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
1.7 |
GO:0042157 |
lipoprotein metabolic process(GO:0042157) |
| 0.0 |
0.5 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.2 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.0 |
0.4 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.0 |
0.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.1 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.0 |
0.2 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.0 |
0.2 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
5.3 |
GO:0007186 |
G-protein coupled receptor signaling pathway(GO:0007186) |
| 0.0 |
0.1 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.0 |
0.1 |
GO:0008216 |
spermidine metabolic process(GO:0008216) |
| 0.0 |
0.3 |
GO:0043470 |
regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
| 0.0 |
0.1 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
0.1 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.1 |
GO:0090312 |
positive regulation of protein deacetylation(GO:0090312) |
| 0.0 |
0.0 |
GO:0002408 |
dendritic cell chemotaxis(GO:0002407) myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.0 |
0.0 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 |
0.1 |
GO:0003014 |
renal system process(GO:0003014) |
| 0.0 |
0.1 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.0 |
6.5 |
GO:0007264 |
small GTPase mediated signal transduction(GO:0007264) |
| 0.0 |
0.1 |
GO:0017157 |
regulation of exocytosis(GO:0017157) |
| 0.0 |
0.1 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.1 |
GO:0019585 |
uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
| 0.0 |
0.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.0 |
GO:0032733 |
positive regulation of interleukin-10 production(GO:0032733) |
| 0.0 |
0.2 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.0 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.0 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.7 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.0 |
GO:0046135 |
pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 |
0.0 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 0.0 |
0.2 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
| 0.0 |
0.0 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
